European Medicines Agency (EMA) virtual press briefing -HPV Safety Review 2015

Jun 23, 2017 | Video

European Medicines Agency (EMA) virtual press briefing – Human papillomavirus (HPV) vaccines

Recommendation from the Pharmacovigilance Risk Assessment Committee (PRAC), 5th November 2015

Comparing reported Adverse Reactions to vaccines in UK

Independent-graph

Follow Us

Recent Tweets

prnewswire.com/news-releases/…
1 day ago • Reply • Retweet • Favorite
RT @dysclinic: A nice case report of #POTS and small fiber #neuropathy after Covid vaccine that responded to #immunotherapy (PLEX). Some of…
2 days ago • Reply • Retweet • Favorite
RT @caronryalls: This is happening in US - nothing in UK - NO media interest at all despite harms to young people in UK. No support for tho…
2 days ago • Reply • Retweet • Favorite
youtube.com/watch?v=KwE7ae…
1 month ago • Reply • Retweet • Favorite
RT @caronryalls: @OPozzuto This was also the case with the #HPVvaccine where follow up was for 14 days and ADRs after this period were left…
1 month ago • Reply • Retweet • Favorite

Follow @TimeForActionUK

Pin It on Pinterest

Share This